Japanese firm that treats rare diseases opens first Canadian office in Mississauga
A major Japanese pharmaceutical company that offers therapies for rare diseases and operates around the globe has opened an ...
Sun Star18h
Trade delegation to Osaka to attend four exhibitions
THE business delegation attending the five-day trade mission to Osaka, Japan, this February will have the opportunity to take ...
Japan projects primary budget surplus in fiscal 2026, delayed by a year
Japan's ambition to deliver a primary budget surplus for the first time in decades is going to be pushed back a year, a ...
Business Wire3d
Shionogi Receives Award Through BARDA's Rapid Response Partnership Vehicle to Advance Long-Acting Formulation of S-892216, an Antiviral for COVID-19 Pre-Expo…
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) ...
BioPharma Dive6d
Regenxbio licenses gene therapies to Japan’s Nippon Shinyaku
Regenxbio, a prolific developer of gene therapy technology, will hand Japan’s Nippon Shinyaku certain rights to two ...